Belite Bio, Inc SEC filings BLTE
Belite Bio, Inc has 214 filings in SEC EDGAR's recent list, going back to Dec 1, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 19, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| S-8 | Employee stock plan registration | Jan 30, 2026 | — |
| 424B5 | Prospectus supplement | Dec 2, 2025 | — |
| 424B5 | Prospectus supplement | Dec 1, 2025 | — |
| F-3ASR | Filing | Oct 22, 2025 | — |
| 424B5 | Prospectus supplement | Aug 8, 2025 | — |
| S-8 | Employee stock plan registration | Mar 21, 2025 | — |
| 424B5 | Prospectus supplement | Feb 7, 2025 | — |
| 424B7 | Filing | Jan 27, 2025 | — |
| F-3ASR | Filing | Jan 27, 2025 | — |
| S-8 | Employee stock plan registration | Oct 1, 2024 | — |
| 424B5 | Prospectus supplement | Apr 29, 2024 | — |
| S-8 | Employee stock plan registration | Sep 19, 2023 | — |
| 424B5 | Prospectus supplement | Jun 16, 2023 | — |
| 424B5 | Prospectus supplement | Jun 1, 2023 | — |
| 424B5 | Prospectus supplement | May 30, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | May 22, 2023 | — |
| F-3 | Shelf registration (foreign issuer) | May 1, 2023 | — |
| S-8 | Employee stock plan registration | Jul 8, 2022 | — |
| 424B4 | Prospectus | Apr 29, 2022 | — |
| F-1/A | Filing | Apr 27, 2022 | — |
| FWP | Free writing prospectus | Apr 25, 2022 | — |
| F-1/A | Filing | Apr 22, 2022 | — |
| F-6 | Filing | Apr 20, 2022 | — |
| FWP | Free writing prospectus | Apr 20, 2022 | — |
| F-1/A | Filing | Apr 20, 2022 | — |
| F-1 | Registration statement (foreign issuer) | Apr 5, 2022 | — |
Showing 26 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- BLTE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- San Diego, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1889109
- Former names
- BELITE BIO, INC (until Oct 30, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.